Halomon (6(R)-Bromo-3(S)-(Bromomethyl)-7-Methyl-2,3,7-Trichloro-1-Octene) is a
polyhalogenated acyclic monoterpene, which was first obtained from the red alga, Portieria
hornemannii (Fuller et al., 1992). Halomon exhibited highly differential cytotoxicity invitro
against brain tumor, renal and colon tumor cell lines in the National Cancer Institute’s
screen (Fuller et al., 1994; Egorin et al., 1996 and 1997; Jung and Parker, 1997 and Sotokawa
et al., 2000). Recent research has shown that Halomon is an inhibitor of the enzyme DNA
Methyl Transferase-1 (DNMT-1), which is responsible for methylation by catalyzing the
transfer of a methyl group from S-Adenosylmethionine to the 5/ position on Cytosine
phosphodiester-linked Guanine dinucleotide (CpG) sites. In many cancers,
hypermethylation at CpG sites silence the promoters of tumor suppressor genes. Thus, the
inhibition of DNMT-1 could potentially reverse tumor growth (Yoo et al., 2002; and
Andrianasolo et al., 2006). The molecular structure of Halomon is given in Figure 1.
An investigation of the three aspects of Halomon were undertaken in the present study:
Structural study of Halomon with the ab-initio and Density Functional Theory (DFT),
calculation of thermodynamic properties of Halomon by B3LYP/6-31G(d, p) method, and
harmonic vibrational frequency calculation at the B3LYP/6-31G (d, p) level.
|